Rabbit Recombinant Monoclonal C2orf69 antibody. Suitable for WB and reacts with Human samples. Cited in 1 publication.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
WB | |
---|---|
Human | Tested |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/1000 | Notes - |
Mitochondrial protein C2orf69, C2orf69
Rabbit Recombinant Monoclonal C2orf69 antibody. Suitable for WB and reacts with Human samples. Cited in 1 publication.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
C2orf69 also known as Chromosome 2 open reading frame 69 is a protein involved in specific cellular functions though the mechanical details remain not completely understood. The molecular mass of C2orf69 is approximately 46 kDa. It shows expression in multiple human tissues with notable presence in the brain and liver. This suggests its involvement in diverse biological processes.
The C2orf69 protein appears implicated in cellular metabolic pathways contributing to energy production and cellular homeostasis. It potentially integrates into larger multi-protein complexes assisting in the regulation of metabolic flow. Its role in such processes emphasizes its importance in normal cell function and growth.
C2orf69 interacts within energy metabolism and mitochondrial function pathways. It may interact with proteins important to these pathways such as those involved in respiratory chain and ATP synthesis. Understanding these interactions helps in deciphering C2orf69’s contribution to cellular metabolism and might provide insights into broader biological mechanisms.
C2orf69 associates with mitochondrial dysfunction and metabolic disorders like Leigh Syndrome and other neurodegenerative diseases. These conditions often involve disruptions in proteins such as NDUFS1 or other complex I components. Connections of C2orf69 with these proteins and diseases highlight potential targets for therapeutic intervention and warrant further investigation into its exact pathological role.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
All lanes: Western blot - Anti-C2orf69 antibody [EPR13713] (ab188870) at 1/1000 dilution
Lane 1: Human stomach lysate at 20 µg
Lane 2: U87-MG lysate at 20 µg
Lane 3: HeLa lysate at 20 µg
All lanes: Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugate at 1/1000 dilution
Predicted band size: 43 kDa
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com